Resources

Type of publications
Regions
Diseases

5255 results found

2024 ∙ Jain, M. Duvendack, M. Shisler, S. Parsekar, S. S. Leon, M. D. A.

Effective interventions for improving routine childhood immunisation in low and middle-income countries: a systematic review of systematic reviews

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Diphtheria
  • Pertussis
  • Tetanus
  • Measles
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Griskaitis, M. Thielemann, I. Schonfeld, V. Falman, A. Scholz, S. Reinacher, U. Haas, L. Wichmann, O. Harder, T.

Effectiveness and duration of protection of primary and booster immunisation against meningococcal serogroup C disease with meningococcal conjugate C and ACWY vaccines: Systematic review

  • Newborn
  • Children
  • Adolescents
  • Meningococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2024 ∙ Fernández-García, S. Del Campo-Albendea, L. Sambamoorthi, D. Sheikh, J. Lau, K. Osei-Lah, N. Ramkumar, A. Naidu, H. Stoney, N. Sundaram, P. Sengupta, P. Mehta, S. Attarde, S. Maddock, S. Manning, M. Meherally, Z. Ansari, K. Lawson, H. Yap, M. Kew, T. Punnoose, A. Knight, C. Sadeqa, E. Cherian, J. Ravi, S. Chen, W. Walker, K. O'Donoghue, K. van Wely, M. van Leeuwen, E. Kostova, E. Kunst, H. Khalil, A. Brizuela, V. Kara, E. Kim, C. R. Thorson, A. Oladapo, O. T. Mofenson, L. Gottlieb, S. L. Bonet, M. Moss, N. Zamora, J. Allotey, J. Thangaratinam, S. Preg, C. O. V. Living Systematic Review Consortium

Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysis

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Li, K. Xia, Y. Ye, H. Sun, X. Shi, B. Wu, J.

Effectiveness and safety of immune response to SARS‑CoV‑2 vaccine in patients with chronic kidney disease and dialysis: A systematic review and meta‑analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Bengolea, A. Chamorro, F. Ramos, J. T. Rada, G. Catalano, H. N. Izcovich, A.

Effectiveness and safety of the recombinant herpes zoster vaccine in different population groups: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Herpes zoster
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Bengolea, A. Scigliano, C. Ramos-Rojas, J. T. Rada, G. Catalano, H. N. Izcovich, A.

Effectiveness and Safety of the Tetravalent Tak-003 Dengue Vaccine: A Systematic Review

  • Children
  • Adolescents
  • Adults
  • Dengue
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Taha, A. M. Mahmoud, A. M. Abouelmagd, K. Saed, S. A. A. Khalefa, B. B. Shah, S. Satapathy, P. Shamim, M. A. Sah, S. Serhan, H. A. Donovan, S. Sah, R. Barboza, J. J.

Effectiveness of a single dose of JYNNEOS vaccine in real world: A systematic review and meta-analysis

  • All age groups
  • Mpox
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Fallucca, A. Priano, W. Carubia, A. Ferro, P. Pisciotta, V. Casuccio, A. Restivo, V.

Effectiveness of Catch-Up Vaccination Interventions Versus Standard or Usual Care Procedures in Increasing Adherence to Recommended Vaccinations Among Different Age Groups: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Before-After Studies

  • All age groups
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Chan, P. S. F. Fang, Y. Cheung, D. H. Zhang, Q. Sun, F. Mo, P. K. H. Wang, Z.

Effectiveness of chatbots in increasing uptake, intention, and attitudes related to any type of vaccination: A systematic review and meta-analysis

  • All age groups
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Dang, W. Long, I. Zhao, Y. Xiang, Y. T. Smith, R. D.

Effectiveness of COVID-19 Vaccines in People with Severe Mental Illness: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...